| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $181K | -26.9% |
| Cost of Revenue | $65K | -71.4% |
| Gross Profit | $117K | +443.7% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $255K | +3.8% |
| Operating Income | -$557K | +36.4% |
| Net Income | -$828K | +30.4% |
| EPS (Basic) | -$0.02 | +60.0% |
| EPS (Diluted) | -$0.02 | +60.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54K | -21.8% |
| Short-term Investments | $649 | +0.0% |
| Inventory | $237K | +2.4% |
| Current Assets | $310K | -4.0% |
| Total Assets | $534K | -12.5% |
| Current Liabilities | $4.6M | +5.0% |
| Total Liabilities | $5.0M | +10.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$439K | -5.1% |
| Investing Cash Flow | -$13K | -129.6% |
| Financing Cash Flow | $436K | +0.3% |
| Stockholders' Equity |
| -$4.4M |
| -14.1% |